These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4383294)

  • 1. Drug responses of three hospital population samples participating in a collaborative study.
    Crane GE; Krummholz W; Lichtigfeldt FJ; Salim T
    Arzneimittelforschung; 1966 Feb; 16(2):290-3. PubMed ID: 4383294
    [No Abstract]   [Full Text] [Related]  

  • 2. Butaperazine in chronic schizophrenic patients: a doubled-blinf study.
    Brotman RK; Muzekari LH; Shanken PM
    Curr Ther Res Clin Exp; 1969 Jan; 11(1):5-8. PubMed ID: 4387485
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 4. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
    [No Abstract]   [Full Text] [Related]  

  • 5. Some effects of mesoridazine (TPS-23) on chronic psychiatric patients.
    Douglas KW; Hindley JP; Kerin MT
    Dis Nerv Syst; 1967 Feb; 28(2):113-7. PubMed ID: 6021590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L
    Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120
    [No Abstract]   [Full Text] [Related]  

  • 7. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 9. [First clinical trails with the "medium tranquilizer" mesoridazine].
    Rhomberg F; Staehelin B
    Schweiz Med Wochenschr; 1967 Apr; 97(16):521-5. PubMed ID: 4875573
    [No Abstract]   [Full Text] [Related]  

  • 10. A pilot study of pimozide in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):706-13. PubMed ID: 5000718
    [No Abstract]   [Full Text] [Related]  

  • 11. Pimozide: a comparative study in the treatment of chronic schizophrenic patients.
    Pinard G; Prénoveau Y; Fliesen W; Elie R; Bielmann P; Lamontagne Y; Tétreault L
    Int J Clin Pharmacol; 1972 Apr; 6(1):22-7. PubMed ID: 4558783
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical studies with propericiazine (R.P. 8909).
    St Jean A; Sterlin C; Noe W; Ban TA
    Dis Nerv Syst; 1967 Aug; 28(8):526-31. PubMed ID: 4383004
    [No Abstract]   [Full Text] [Related]  

  • 13. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems in the evaluation of the optimal dose of a phenothiazine (butaperazine).
    Simpson GM; Amin M; Kunz-Bartholini E; Watts TP; Laska E
    Dis Nerv Syst; 1968 Jul; 29(7):478-84. PubMed ID: 4386374
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial with Sulpiride and placebo in chronic schizophrenics (study of 89 patients using the Harris-Letemendía-Willems scale)].
    Mezquita Blanco J; Cubillo Sánchez J; Aizpiri Díaz J; Zubia Zubia B
    Arch Neurobiol (Madr); 1972; 35(5):453-72. PubMed ID: 4568565
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes in chronic schizophrenia.
    Marinow A
    Dis Nerv Syst; 1971 Nov; 32(11):777-8. PubMed ID: 5131772
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of lobotomized schizophrenic patients with butaperazine.
    Holden JM; Itil TM; Keskiner A
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):418-28. PubMed ID: 4390417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of ethopropazine and trihexyphenidyl on several parameters of the neuroleptic syndrome].
    Elie R; Morin L; Tétreault L
    Encephale; 1972; 61(1):32-52. PubMed ID: 4403697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of Navane concentrate and tablets].
    Radmayr E
    Wien Z Nervenheilkd Grenzgeb; 1968; 26(4):340-60. PubMed ID: 4241209
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.